Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Neoplasms × Platinum × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 6 Lung Neoplasms 6 Oropharyngeal Neoplasms 4 Mesothelioma, Malignant 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Laryngeal Neoplasms 3 Breast Neoplasms 3 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoid Interstitial Pneumonia 2 Hypopharyngeal Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma 2 Vaginal Neoplasms 1 Urethral Neoplasms 1 Tongue Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Solid Neoplasms 1 Sinonasal undifferentiated carcinoma 1 Salivary Gland Neoplasms 1 SCLC 1 Prostatic Neoplasms 1 Penile Neoplasms 1 Pathologic Complete Response 1

Interventions

pembrolizumab 1 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420884 2025-06-13

iintune-1

Takeda

Phase 1/2 Active not recruiting

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡